These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1713983)

  • 1. Effects of bradykinin on inducible sustained ventricular tachycardia two weeks after myocardial infarction in pigs.
    Tobé TJ; de Langen CD; Tio RA; Bel KJ; Mook PH; Wesseling H
    J Cardiovasc Pharmacol; 1991 May; 17(5):701-6. PubMed ID: 1713983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig.
    de Langen CD; de Graeff PA; van Gilst WH; Bel KJ; Kingma JH; Wesseling H
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):186-91. PubMed ID: 2468944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig.
    Tuininga YS; De Langen CD; Crijns HJ; Wiesfeld AC; Mook PH; Bel KJ; Lie KI
    Pacing Clin Electrophysiol; 1996 May; 19(5):802-10. PubMed ID: 8734747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effect of bradykinin during ischemia and reperfusion: improved electrical stability two weeks after myocardial infarction in the pig.
    Tobé TJ; de Langen CD; Tio RA; Bel KJ; Mook PH; Wesseling H
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):600-7. PubMed ID: 1711627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
    Kus T; Costi P; Dubuc M; Shenasa M
    Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous captopril on inducible sustained ventricular tachycardia one week after experimental infarction in the anaesthetized pig.
    Kingma JH; de Graeff PA; van Gilst WH; van Binsbergen E; de Langen CD; Wesseling H
    Postgrad Med J; 1986; 62 Suppl 1():159-63. PubMed ID: 3534853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
    Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isradipine on hemodynamic parameters and ventricular tachycardia in healed myocardial infarction.
    de Langen CD; van den Toren EW; Tio RA; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):254-8. PubMed ID: 1689421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
    Zuanetti G; Corr PB
    J Pharmacol Exp Ther; 1991 Jan; 256(1):325-34. PubMed ID: 1988663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction.
    Buxton AE; Simson MB; Falcone RA; Marchlinski FE; Doherty JU; Josephson ME
    Am J Cardiol; 1987 Jul; 60(1):80-5. PubMed ID: 3604948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of bradykinin on porcine ischemic myocardium.
    Tio RA; Tobé TJ; Bel KJ; de Langen CD; van Gilst WH; Wesseling H
    Basic Res Cardiol; 1991; 86(2):107-16. PubMed ID: 1877966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction.
    Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR
    Pharmacology; 1987; 35(4):181-93. PubMed ID: 3118399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs.
    Tobé TJ; de Langen CD; Weersink EG; van Wijngaarden J; Bel KJ; de Graeff PA; van Gilst WH; Wesseling H
    J Cardiovasc Pharmacol; 1992 May; 19(5):732-40. PubMed ID: 1381771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic effects of procainamide and tocainide in a canine infarction model.
    Steinberg JS; Sahar DI; Rosenbaum M; Cook JR; Bigger JT
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):52-9. PubMed ID: 1375688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Am Heart J; 1994 Feb; 127(2):345-52. PubMed ID: 7507635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
    Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
    Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
    Denniss AR; Ross DL; Richards DA; Cody DV; Russell PA; Young AA; Uther JB
    Am J Cardiol; 1986 Aug; 58(3):261-5. PubMed ID: 3739914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
    Black SC; Butterfield JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.